213 related articles for article (PubMed ID: 29087712)
1. Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.
Al-Awadhi FH; Law BK; Paul VJ; Luesch H
J Nat Prod; 2017 Nov; 80(11):2969-2986. PubMed ID: 29087712
[TBL] [Abstract][Full Text] [Related]
2. Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium.
Al-Awadhi FH; Ratnayake R; Paul VJ; Luesch H
Bioorg Med Chem; 2016 Aug; 24(15):3276-82. PubMed ID: 27211244
[TBL] [Abstract][Full Text] [Related]
3. Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.
Kwan JC; Eksioglu EA; Liu C; Paul VJ; Luesch H
J Med Chem; 2009 Sep; 52(18):5732-47. PubMed ID: 19715320
[TBL] [Abstract][Full Text] [Related]
4. Grassystatin-derived peptides selectively inhibit cathepsin E and have low affinity to cathepsin D.
Stotz S; Bleher D; Kalbacher H; Maurer A
Biochem Biophys Res Commun; 2020 Jun; 527(1):238-241. PubMed ID: 32446374
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis of grassystatin A, a probe for cathepsin E function.
Yang S; Zhang W; Ding N; Lo J; Liu Y; Clare-Salzler MJ; Luesch H; Li Y
Bioorg Med Chem; 2012 Aug; 20(15):4774-80. PubMed ID: 22748705
[TBL] [Abstract][Full Text] [Related]
6. The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.
Miller B; Friedman AJ; Choi H; Hogan J; McCammon JA; Hook V; Gerwick WH
J Nat Prod; 2014 Jan; 77(1):92-9. PubMed ID: 24364476
[TBL] [Abstract][Full Text] [Related]
7. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
[TBL] [Abstract][Full Text] [Related]
8. Aspartic cathepsin D degrades the cytosolic cysteine cathepsin inhibitor stefin B in the cells.
Železnik TZ; Kadin A; Turk V; Dolenc I
Biochem Biophys Res Commun; 2015 Sep; 465(2):213-7. PubMed ID: 26239660
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells.
Magister S; Obermajer N; Mirković B; Svajger U; Renko M; Softić A; Romih R; Colbert JD; Watts C; Kos J
Eur J Cell Biol; 2012 May; 91(5):391-401. PubMed ID: 22365146
[TBL] [Abstract][Full Text] [Related]
10. Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.
Thomssen C; Oppelt P; Jänicke F; Ulm K; Harbeck N; Höfler H; Kuhn W; Graeff H; Schmitt M
Anticancer Res; 1998; 18(3C):2173-80. PubMed ID: 9703780
[TBL] [Abstract][Full Text] [Related]
11. Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases.
Liu Y; Zhang W; Li L; Salvador LA; Chen T; Chen W; Felsenstein KM; Ladd TB; Price AR; Golde TE; He J; Xu Y; Li Y; Luesch H
J Med Chem; 2012 Dec; 55(23):10749-65. PubMed ID: 23181502
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer.
Harbeck N; Alt U; Berger U; Kates R; Krüger A; Thomssen C; Jänicke F; Graeff H; Schmitt M
Int J Biol Markers; 2000; 15(1):79-83. PubMed ID: 10763146
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
Jung M; Lee J; Seo HY; Lim JS; Kim EK
PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
[TBL] [Abstract][Full Text] [Related]
14. Major acid endopeptidases of the blood-feeding monogenean Eudiplozoon nipponicum (Heteronchoinea: Diplozoidae).
Jedličková L; Dvořáková H; Kašný M; Ilgová J; Potěšil D; Zdráhal Z; Mikeš L
Parasitology; 2016 Apr; 143(4):494-506. PubMed ID: 26888494
[TBL] [Abstract][Full Text] [Related]
15. Menadione-induced apoptosis in U937 cells involves Bid cleavage and stefin B degradation.
Božič J; Bidovec K; Vizovišek M; Dolenc I; Stoka V
J Cell Biochem; 2019 Jun; 120(6):10662-10669. PubMed ID: 30652348
[TBL] [Abstract][Full Text] [Related]
16. Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.
Xu H; Bao K; Tang S; Ai J; Hu H; Zhang W
J Pept Sci; 2017 Sep; 23(9):701-706. PubMed ID: 28585417
[TBL] [Abstract][Full Text] [Related]
17. [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
Khalikova TA; Korolenko TA; Il'nitskaia SI
Biomed Khim; 2009; 55(5):621-34. PubMed ID: 20017393
[TBL] [Abstract][Full Text] [Related]
18. Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.
Lützner N; Kalbacher H
J Biol Chem; 2008 Dec; 283(52):36185-94. PubMed ID: 18957408
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal digestion of thyroglobulin: role of cathepsin D and thiol proteases.
Yoshinari M; Taurog A
Endocrinology; 1985 Oct; 117(4):1621-31. PubMed ID: 3896765
[TBL] [Abstract][Full Text] [Related]
20. Symplocin A, a linear peptide from the Bahamian cyanobacterium Symploca sp. Configurational analysis of N,N-dimethylamino acids by chiral-phase HPLC of naphthacyl esters.
Molinski TF; Reynolds KA; Morinaka BI
J Nat Prod; 2012 Mar; 75(3):425-31. PubMed ID: 22360587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
